Serological tests using sera from patients who experienced thrombocytopenia and thrombosis after vaccination revealed high reactivity in anti-PF4/heparin enzyme immunoassays and strong platelet-activating antibodies that are positive (Wrapp et al., 2020). This evidence concerns the gene PF4 and Thrombocytopenia.